Login to Your Account

Phase III Antegren Data Show Benefit For Crohn's Continues

By Randall Osborne

Thursday, May 20, 2004
Offering new data for Antegren against Crohn's disease, Biogen Idec Inc. said it will file for approval in the European Union but is conducting another study in the U.S. before seeking approval here. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription